Eliot Bourk
Corporate Officer/Principal at CHIMERIC THERAPEUTICS LIMITED
Net worth: 82 412 $ as of 29/04/2024
Profile
Eliot Bourk is currently the Chief Business Officer & Head-External Innovation at Chimeric Therapeutics Ltd.
(Australia).
Previously, he worked at Celgene Corp.
as a Member.
He holds a doctorate degree from the University of California.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/06/2023 | 4,230,603 ( 0.50% ) | 82 412 $ | 29/04/2024 |
Eliot Bourk active positions
| Companies | Position | Start |
|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Corporate Officer/Principal | 22/02/2021 |
Former positions of Eliot Bourk
| Companies | Position | End |
|---|---|---|
| CELGENE | Corporate Officer/Principal | - |
Training of Eliot Bourk
| University of California | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Stock Market
- Insiders
- Eliot Bourk
